Ozempic & Wegovy Drive Major Shifts in Consumer Spending, New Data Shows
WASHINGTON D.C. – A surge in the use of GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound is dramatically reshaping American consumer behavior, impacting everything from grocery bills to alcohol consumption, according to recent reports from The Washington Post, Gallup, Numerator, and NIQ. The percentage of U.S.adults using these drugs more than doubled in just over a year, reaching 12.4% according to a gallup survey. Simultaneously, the national obesity rate has seen a decline, falling from nearly 40% in 2022 to 37% in 2025.
This shift is prompting businesses across multiple sectors to adapt. Companies are acquiring health food brands, renovating fitness facilities, and adjusting restaurant menus to cater to the evolving needs of GLP-1 users.
At the pharmacy, sales of supplements and vitamin-rich beauty products are experiencing a boom. Specifically, purchases of electrolytes, hair-growth products, and anti-nausea medications are on the rise among those taking GLP-1s.
Grocery spending among GLP-1 users has decreased by 10% over the past year across 100 categories, including groceries, quick-service restaurants, and tobacco, as reported by Numerator. A notable trend is a reduction in alcohol purchases, with GLP-1 users spending 14.5% less in that category after starting treatment. Though, purchases of nonalcoholic wine and beer have skyrocketed, increasing by 1,158% and 935% respectively, according to NIQ. High-protein drinks and probiotic sodas, already popular for gut health, are also seeing notable growth.
The data also indicates a move towards home cooking. Users reduced spending on dining out by 8.6% in the six months following the start of medication, according to Numerator and cornell University.
costco recently announced it will begin selling Ozempic and Wegovy to members with a prescription, priced at $499 for a four-week supply.
Further insights into attracting the growing GLP-1 consumer base can be found in the June 2025 issue of NACS Magazine article, “Targeting the GLP-1 Shopper.”
